KRAS and non-small cell lung carcinoma: We found that LPIAT1 significantly suppressed the proliferation of mutant KRAS NSCLC cell lines A549, A427, H1264, and H358 (Fig. 2d) as well as that of ACSL3-dependent wild-type KRAS NSCLC cell lines, H125 and HCC95 but had no impact on the proliferation of H596 and H838 cell lines (Supplementary Fig. 2D).